Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases
<p>Abstract</p> <p>Colorectal small cell carcinoma (SmCC) is a rare tumor with an aggressive course. The aim of this study is to summarize our experience with this tumor and to highlight its immunohistochemical profile. Ten cases of colorectal SmCC were identified in our files and...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-09-01
|
Series: | Diagnostic Pathology |
Online Access: | http://www.diagnosticpathology.org/content/2/1/35 |
id |
doaj-7c03fefe73774a64961adcfb87a131c1 |
---|---|
record_format |
Article |
spelling |
doaj-7c03fefe73774a64961adcfb87a131c12020-11-25T01:56:13ZengBMCDiagnostic Pathology1746-15962007-09-01213510.1186/1746-1596-2-35Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 casesWong ShunIsmiil NadiaKhalifa Mahmoud AEl Demellawy DinaGhorab Zeina<p>Abstract</p> <p>Colorectal small cell carcinoma (SmCC) is a rare tumor with an aggressive course. The aim of this study is to summarize our experience with this tumor and to highlight its immunohistochemical profile. Ten cases of colorectal SmCC were identified in our files and a panel of immunostains was performed. Follow up was available for the average of 3 years, during which 7 patients died and 3 were alive with disease. All cases were positive for LMWK, CK 19 and pancytokeratin but were negative for TTF-1 and CA 125. EGFR was positive in 7 cases. TTF-1 negative staining may be valuable in differentiating it from its pulmonary counterpart. CDX2, mCEA, CD56, synaptophysin, NSE and chromogranin can help differentiate it from non-endocrine poorly differentiated adenocarcinoma. The expression of EGFR in a subset of patients has not been reported earlier and has to be evaluated in larger series to assess its role in the planning of targeted biologic therapy.</p> http://www.diagnosticpathology.org/content/2/1/35 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wong Shun Ismiil Nadia Khalifa Mahmoud A El Demellawy Dina Ghorab Zeina |
spellingShingle |
Wong Shun Ismiil Nadia Khalifa Mahmoud A El Demellawy Dina Ghorab Zeina Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases Diagnostic Pathology |
author_facet |
Wong Shun Ismiil Nadia Khalifa Mahmoud A El Demellawy Dina Ghorab Zeina |
author_sort |
Wong Shun |
title |
Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases |
title_short |
Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases |
title_full |
Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases |
title_fullStr |
Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases |
title_full_unstemmed |
Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases |
title_sort |
primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases |
publisher |
BMC |
series |
Diagnostic Pathology |
issn |
1746-1596 |
publishDate |
2007-09-01 |
description |
<p>Abstract</p> <p>Colorectal small cell carcinoma (SmCC) is a rare tumor with an aggressive course. The aim of this study is to summarize our experience with this tumor and to highlight its immunohistochemical profile. Ten cases of colorectal SmCC were identified in our files and a panel of immunostains was performed. Follow up was available for the average of 3 years, during which 7 patients died and 3 were alive with disease. All cases were positive for LMWK, CK 19 and pancytokeratin but were negative for TTF-1 and CA 125. EGFR was positive in 7 cases. TTF-1 negative staining may be valuable in differentiating it from its pulmonary counterpart. CDX2, mCEA, CD56, synaptophysin, NSE and chromogranin can help differentiate it from non-endocrine poorly differentiated adenocarcinoma. The expression of EGFR in a subset of patients has not been reported earlier and has to be evaluated in larger series to assess its role in the planning of targeted biologic therapy.</p> |
url |
http://www.diagnosticpathology.org/content/2/1/35 |
work_keys_str_mv |
AT wongshun primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases AT ismiilnadia primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases AT khalifamahmouda primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases AT eldemellawydina primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases AT ghorabzeina primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases |
_version_ |
1724980806268485632 |